115 filings
8-K
NRIX
Nurix Therapeutics Inc
21 May 24
Submission of Matters to a Vote of Security Holders
7:06am
8-K
NRIX
Nurix Therapeutics Inc
12 Apr 24
Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering
5:12pm
424B5
NRIX
Nurix Therapeutics Inc
12 Apr 24
Prospectus supplement for primary offering
5:10pm
424B5
NRIX
Nurix Therapeutics Inc
11 Apr 24
Prospectus supplement for primary offering
4:06pm
10-Q
2024 Q1
NRIX
Nurix Therapeutics Inc
Quarterly report
10 Apr 24
7:06am
8-K
v6ek9dd6uf
10 Apr 24
Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Update
7:02am
8-K
4k8h0kb
9 Apr 24
Other Events
1:17pm
ARS
sftf e02zs
27 Mar 24
Annual report to shareholders
7:03am
DEFA14A
t9j0fh
27 Mar 24
Additional proxy soliciting materials
7:02am
8-K
ems6btzagofni0qlsmrq
11 Mar 24
Nurix Therapeutics Announces U.S. FDA Lifts Partial Clinical Hold on NX-2127 Phase 1 Trial
7:02am
S-8
rxnpfa6y
15 Feb 24
Registration of securities for employees
4:51pm
8-K
lywh8s76y uyyxg26l
15 Feb 24
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides a Corporate Update
4:01pm
8-K
2qm8aqfad1jzesc308dh
8 Jan 24
Regulation FD Disclosure
7:03am
8-K
da00ogfs08 vjkfos8
11 Dec 23
Other Events
12:03pm
8-K
6pc7q4pew0
13 Nov 23
Regulation FD Disclosure
7:01am
8-K
g0g0ryb v1zr
1 Nov 23
Nurix Therapeutics Announces Partial Clinical Hold For NX-2127 Phase 1 Trial
4:02pm
8-K
tfi4cak 2kr
12 Oct 23
Nurix Therapeutics Reports Third Quarter Fiscal 2023 Financial Results and Provides a Corporate Update
4:03pm